Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021;35:787–820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467–80.

Article  PubMed  Google Scholar 

Bresalier RS. Colorectal cancer screening in a changing world. Gastroenterol Clin North Am. 2022;51:577–91.

Article  PubMed  Google Scholar 

Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets. 2021;22:998–1009.

Article  CAS  PubMed  Google Scholar 

Sinha R. Colorectal cancer. Clin Radiol. 2021;76:870.

Article  CAS  PubMed  Google Scholar 

Messersmith WA. NCCN guidelines updates: management of metastatic colorectal cancer. J Natl Compr Canc Netw. 2019;17:599–601.

PubMed  Google Scholar 

Väyrynen V, Wirta E-V, Seppälä T, Sihvo E, Mecklin J-P, Vasala K, et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open. 2020;4:685–92.

Article  PubMed  PubMed Central  Google Scholar 

Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:10–32.

Article  CAS  PubMed  Google Scholar 

Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin. 2022;72:372–401.

Article  PubMed  Google Scholar 

Van Cutsem E, Lenz H-J, Köhne C-H, Heinemann V, Tejpar S, Melezínek I, et al. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J Clin Oncol. 2015;33:692–700.

Article  PubMed  Google Scholar 

Klimeck L, Heisser T, Hoffmeister M, Brenner H. Colorectal cancer: a health and economic problem. Best Pract Res Clin Gastroenterol. 2023;66: 101839.

Article  PubMed  Google Scholar 

Siegel RL, Jakubowski CD, Fedewa SA, Davis A, Azad NS. Colorectal cancer in the young: epidemiology, prevention, management. Am Soc Clin Oncol Educ Book. 2020;40:1–14.

PubMed  Google Scholar 

Aziz MA, Yousef Z, Saleh AM, Mohammad S, Al KB. Towards personalized medicine of colorectal cancer. Crit Rev Oncol Hematol. 2017;118:70–8.

Article  PubMed  Google Scholar 

Aquino de Moraes FC, Dantas Leite Pessôa FD, de Castro Duarte, Ribeiro CH, Rodrigues Fernandes M, Rodríguez Burbano RM, Carneiro Dos Santos NP. Trifluridine-tipiracil plus bevacizumab versus trifluridine-tipiracil monotherapy for chemorefractory metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer. 2024;24:674.

Article  CAS  PubMed  Google Scholar 

Saif MW. Colorectal cancer in review: the role of the EGFR pathway. Expert Opin Investig Drugs. 2010;19:357–69.

Article  CAS  PubMed  Google Scholar 

Linnekamp JF, Wang X, Medema JP, Vermeulen L. Colorectal cancer heterogeneity and targeted therapy: a case for molecular disease subtypes. Cancer Res. 2015;75:245–9.

Article  CAS  PubMed  Google Scholar 

Dantas AAG, de Oliveira NPD, Costa GAB, Martins LFL, Dos Santos JEM, Migowski A, et al. Multilevel analysis of social determinants of advanced stage colorectal cancer diagnosis. Sci Rep. 2024;14:9667.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Misale S, Di Nicolantonio F, Sartore-Bianchi A, Siena S, Bardelli A. Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution. Cancer Discov. 2014;4:1269–80.

Article  CAS  PubMed  Google Scholar 

Sur D, Havasi A, Gorzo A, Burz C. A critical review of second-generation anti-EGFR monoclonal antibodies in metastatic colorectal cancer. Curr Drug Targets. 2021;22:1034–42.

Article  CAS  PubMed  Google Scholar 

Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44:222–36.

Article  CAS  PubMed  Google Scholar 

Kim BJ, Hanna MH. Colorectal cancer in young adults. J Surg Oncol. 2023;127:1247–51.

Article  PubMed  Google Scholar 

Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer. World J Gastroenterol. 2023;29:1569–88.

Article  CAS  PubMed  Google Scholar 

Ashktorab H, Brim H. Colorectal cancer subtyping. Nat Rev Cancer. 2022;22:68–9.

Article  CAS  PubMed  Google Scholar 

Watanabe J, Muro K, Shitara K, Yamazaki K, Shiozawa M, Ohori H, et al. Panitumumab vs bevacizumab added to standard first-line chemotherapy and overall survival among patients with RAS wild-type, left-sided metastatic colorectal cancer: a randomized clinical trial. JAMA. 2023;329:1271–82.

Article  CAS  PubMed  Google Scholar 

Li Q-H, Wang Y-Z, Tu J, Liu C-W, Yuan Y-J, Lin R, et al. Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance. Gastroenterol Rep (Oxf). 2020;8:179–91.

Article  PubMed  Google Scholar 

Birkman E-M, Avoranta T, Ålgars A, Korkeila E, Lintunen M, Lahtinen L, et al. EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer. Hum Pathol. 2018;82:163–71.

Article  CAS  PubMed  Google Scholar 

Napolitano S, Martini G, Ciardiello D, Del Tufo S, Martinelli E, Troiani T, et al. Targeting the EGFR signalling pathway in metastatic colorectal cancer. Lancet Gastroenterol Hepatol. 2024;9:664–76.

Article  CAS  PubMed  Google Scholar 

Ogunwobi OO, Mahmood F, Akingboye A. Biomarkers in colorectal cancer: current research and future prospects. Int J Mol Sci. 2020;21:5311.

Article  CAS  PubMed  Google Scholar 

Randon G, Yaeger R, Hechtman JF, Manca P, Fucà G, Walch H, et al. EGFR amplification in metastatic colorectal cancer. J Natl Cancer Inst. 2021;113:1561–9.

Article  PubMed  Google Scholar 

Li D, Fu Q, Li M, Li J, Yin C, Zhao J, et al. Primary tumor site and anti-EGFR monoclonal antibody benefit in metastatic colorectal cancer: a meta-analysis. Future Oncol. 2017;13:1115–27.

Article  CAS  PubMed  Google Scholar 

Martins M, Mansinho A, Cruz-Duarte R, Martins SL, Costa L. Anti-EGFR therapy to treat metastatic colorectal cancer: not for all. Adv Exp Med Biol. 2018;1110:113–31.

Article  CAS  PubMed  Google Scholar 

Doleschal B, Petzer A, Rumpold H. Current concepts of anti-EGFR targeting in metastatic colorectal cancer. Front Oncol. 2022;12:1048166.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.

Article  PubMed